102
Participants
Start Date
April 11, 2017
Primary Completion Date
August 29, 2025
Study Completion Date
March 31, 2026
Clofazimine
All participants in the experimental/treatment arm on this protocol will take a loading dose of 200 mg daily in soft capsule form of clofazimine for 16 weeks, dropping to 100 mg daily for the next 8 weeks.
sugar pill
All participants in the placebo arm on this protocol will take placebo in soft capsule form daily dropping to a smaller dose after 16 weeks to mirror the treatment arm dosing.
National Heart, Lung and Blood Institute, Bethesda
University of South Florida, Tampa
University of Chicago, Chicago
Louisiana State University, Baton Rouge
University of Texas Health Science Center, Tyler
National Jewish Health, Denver
Oregon Health & Science University, Portland
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Jewish Health
OTHER
The University of Texas Health Science Center at Tyler
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of Chicago
OTHER
Temple University
OTHER
University of South Florida
OTHER
Oregon Health and Science University
OTHER